1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014

Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014" provides data on the Pemphigus Vulgaris clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pemphigus Vulgaris. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pemphigus Vulgaris. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 5
Pemphigus Vulgaris 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Pemphigus Vulgaris to Immunology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Pemphigus Vulgaris to Immunology Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Pemphigus Vulgaris 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Pemphigus Vulgaris Therapeutics Clinical Trials 25
Prominent Drugs 26
Latest Clinical Trials News on Pemphigus Vulgaris 27
Oct 07, 2014: Stiefel, a GSK company, announces start of phase III study of subcutaneous ofatumumab for pemphigus vulgaris 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Novartis AG 28
Clinical Trial Overview of Novartis AG 28
Kemia, Inc. 29
Clinical Trial Overview of Kemia, Inc. 29
Jacobus Pharmaceutical Company 30
Clinical Trial Overview of Jacobus Pharmaceutical Company 30
GlaxoSmithKline plc 31
Clinical Trial Overview of GlaxoSmithKline plc 31
Genzyme Corporation 32
Clinical Trial Overview of Genzyme Corporation 32
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of Top Institutes / Government 34
University Medical Center Groningen 34
Clinical Trial Overview of University Medical Center Groningen 34
Tehran University of Medical Sciences 35
Clinical Trial Overview of Tehran University of Medical Sciences 35
The National Institute of Allergy and Infectious Diseases 36
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 36
University of Heidelberg 37
Clinical Trial Overview of University of Heidelberg 37
Shiraz University of Medical Sciences 38
Clinical Trial Overview of Shiraz University of Medical Sciences 38
Northwestern University 39
Clinical Trial Overview of Northwestern University 39
University Hospital, Toulouse 40
Clinical Trial Overview of University Hospital, Toulouse 40
New York University School of Medicine 41
Clinical Trial Overview of New York University School of Medicine 41
Massachusetts General Hospital 42
Clinical Trial Overview of Massachusetts General Hospital 42
Philipps University Marburg Medical Center 43
Clinical Trial Overview of Philipps University Marburg Medical Center 43
Five Key Clinical Profiles 44
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 68

List of Tables

Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Region, 2014* 6
Pemphigus Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Pemphigus Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Pemphigus Vulgaris Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Pemphigus Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Pemphigus Vulgaris Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Pemphigus Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Pemphigus Vulgaris to Immunology Clinical Trials, G7 Countries (%), 2014* 13
Pemphigus Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Pemphigus Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Pemphigus Vulgaris to Immunology Clinical Trials, E7 Countries (%), 2014* 16
Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Pemphigus Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Pemphigus Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Pemphigus Vulgaris Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Pemphigus Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 28
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Kemia, Inc., 2014* 29
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Jacobus Pharmaceutical Company, 2014* 30
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 31
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2014* 32
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 33
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2014* 34
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 35
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 36
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2014* 37
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 38
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 39
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2014* 40
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 41
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 42
Pemphigus Vulgaris Therapeutics Clinical Trials Market, Global, Clinical Trials by Philipps University Marburg Medical Center, 2014* 43

List of Figures

Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Pemphigus Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Pemphigus Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Pemphigus Vulgaris Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Pemphigus Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Pemphigus Vulgaris Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Pemphigus Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 12
Proportion of Pemphigus Vulgaris to Immunology Clinical Trials, G7 Countries (%), 2014* 13
Pemphigus Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Pemphigus Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Pemphigus Vulgaris to Immunology Clinical Trials, E7 Countries (%), 2014* 16
Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Pemphigus Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Pemphigus Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Pemphigus Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Pemphigus Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Pemphigus Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 67

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.